Article specifically refers to vaccination with live attenuated virus... Should a difference be inferred between Shingrix and Zostavax (in the context of the effect on dementia, not shingles)
Background to the question is providers here seem to be switching to Shingrix for (claimed) higher effectiveness against shingles, but there's at least some suggestion that Shingix is not live (attenuated) virus...